Table 1.
Distribution of Immunotypes by Clinical factors
| Immunotype | P value* | |||||||
|---|---|---|---|---|---|---|---|---|
| A | B | C | ||||||
| N | (%) | N | (%) | N | (%) | |||
| Total | 42 | (28.6) | 93 | (63.3) | 12 | (8.2) | ||
| Cell Type | E | 28 | (24.3) | 77 | (67.0) | 10 | (8.7) | 0.08 |
| M | 10 | (47.6) | 11 | (52.4) | . | . | ||
| S | 4 | (36.4) | 5 | (45.5) | 2 | (18.2) | ||
| Stage | III | 28 | (27.2) | 66 | (64.1) | 9 | (8.7) | 0.57 |
| IV | 14 | (31.8) | 27 | (61.4) | 3 | (6.8) | ||
| Gender | F | 17 | (27.0) | 43 | (68.3) | 3 | (4.8) | 0.71 |
| M | 25 | (29.8) | 50 | (59.5) | 9 | (10.7) | ||
| Tissue | Lymph Node | 18 | (25.0) | 47 | (65.3) | 7 | (9.7) | 0.35 |
| Peritoneum | . | . | 1 | (100.0) | . | . | ||
| Small Bowel | 3 | (50.0) | 3 | (50.0) | . | . | ||
| Skin/SQ | 21 | (30.9) | 42 | (61.8) | 5 | (7.4) | ||
| Age | <50 | 14 | (27.5) | 34 | (66.7) | 3 | (5.9) | 0.87 |
| >=50 & <70 | 15 | (27.3) | 35 | (63.6) | 5 | (9.1) | ||
| >=70 | 13 | (31.7) | 24 | (58.5) | 4 | (9.8) | ||
| Prior Vax | N | 35 | (28.7) | 78 | (63.9) | 9 | (7.4) | 0.94 |
| Y | 7 | (28.0) | 15 | (60.0) | 3 | (12.0) | ||
| NED after surgery? |
N | 13 | (35.1) | 23 | (62.2) | 1 | (2.7) | 0.31 |
| Y | 29 | (26.4) | 70 | (63.6) | 11 | (10.0) | ||
*
Chi-square test of association: A vs B+C